English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

News Medical

Patient Daily | Dec 25, 2025

Engineered oncolytic bacteria offer new strategies for targeted cancer therapy

Patient Daily | Dec 25, 2025

Study identifies Fibulin-7 as driver of adipose tissue fibrosis and possible therapy target

Patient Daily | Dec 25, 2025

Study finds single DNA-histone link can block key genetic processes

Patient Daily | Dec 25, 2025

Immune checkpoint inhibitor therapy linked to rare but serious blood disorder in cancer patients

Patient Daily | Dec 25, 2025

Rural hospitals face challenges after Trump administration raises H-1B visa fee

Patient Daily | Dec 25, 2025

SereNeuro unveils data on stem cell-based therapy for chronic osteoarthritis pain

Patient Daily | Dec 25, 2025

Early relapse linked to poor prognosis in mature nodal T-cell lymphoma

Patient Daily | Dec 25, 2025

Project launched to reduce noise exposure for premature infants in neonatal care

Trending

Patient Daily | Mar 6, 2026

Dallas Breathe Free ranked top ENT practice in region by reviewers on Google

+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

FDA prepares decisions on key drugs from BMS, GSK, Aldeyra and others

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Merck and Pfizer report positive phase 3 results for bladder cancer drug combination

  • « First
  • «
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily